Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
Biopharma layoff rate stabilizes in Q3: Fierce Biotech analysis
August saw a surge in workforce reductions, with 21 rounds reported, compared to July’s 17 and September’s 11.
Gabrielle Masson
Oct 4, 2024 3:50pm
Big Pharma backers return for Aktis' $175M series B
Sep 30, 2024 8:00am
BMS pays Prime $110M to form T-cell therapy pact
Sep 30, 2024 7:18am
ESMO: Bristol Myers axes Immatics' bispecific after $150M bet
Sep 16, 2024 6:59am
ESMO: Regeneron's Opdualag rival shows 57% response rate
Sep 14, 2024 3:00am
ESMO: Cancer vaccine and Keytruda deliver in phase 2 trial
Sep 14, 2024 2:30am